You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海醫藥(02607.HK)擬計提商譽減值準備4.86億元
格隆匯 03-23 17:58

格隆匯 3 月 23日丨上海醫藥(02607.HK)發佈關於計提商譽減值準備的公吿,公司於2021年3月23日召開第七屆董事會第十九次會議,審議通過了《關於計提商譽減值準備的議案》。為客觀、公允地反映公司經營狀況,公司於2020年聘任上海東洲資產評估有限公司(以下簡稱“東洲評估”)作為第三方評估機構對公司商譽減值事項進行評估和測定。

公吿表示,公司管理層根據相關規定,結合公司當期實際經營情況,以東洲評估對各資產組可回收價值的測算結果為基礎,秉着謹慎性原則對公司收購Big Global Limited、甘肅信誼天森藥業有限公司、浙江九旭藥業有限公司以及山東上藥中藥飲片有限公司形成的上述4個資產組商譽計提減值準備,金額合計人民幣48,626.94萬元。本次計提商譽減值準備金額合計約為人民幣48,626.94萬元,減少公司2020年度合併報表歸屬於母公司所有者的淨利潤約為人民幣47,804.52萬元(最終數據以公司將披露的2020年年度報吿為準)。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account